摘要
目的将体外由CD34^+细胞分化而来的初始T细胞与异基因骨髓间充质干细胞(MSC)共孵育,观察初始T细胞表型的变化。方法传3代以上的MSC与脐血CD34^+刍细胞分化的初始T细胞共孵育1周,用流式细胞仪检测其表型变化。结果与对照组相比,CD8^+细胞明显增加(共孵育组(35.9±6.3)%,单纯初始T细胞培养组(18.4±4.5)%],且CD8^+;CD3^+细胞明显增加[共孵育组(27.6±2.8)%,单纯初始T细胞培养组(15.2±3.1)%]。结论骨髓MSC在体外与异基因初始T淋巴细胞共孵育使CD8^+初始T细胞表达增加,这种变化可能与其诱导免疫耐受相关。
Objective Donor derived naive T cells initiated GVHD by contacting with, mesenchymal stem cells (MSC) have been used to prevent or treat graft-versus-host disease (GVHD). although we still puzzle about its mechanisms. Observe the effect of MSC on phenotypes of Naive T cell to study the mechanism of MSC immunomodulation. Methods After 3 passages, MSC was incubated with Naive T cell differentiated from cord blood CD^34+ cells in vitro. Then the variances of naive T cell phenotypes were analyzed by flow cytometric. Results CD8^+ T cells were relatively increased after 7 days co-culture with allogenie MSC when compared to control: (35.9±6.3)% vs (18.4±4.5)%. CD8^+ CD; cells also showed the same trend (27.6±2.8)% vs (15.2±3.1)%. Conclusion MSC may partly reduce the incidence of GVHD by increase of CD8^+ naive T cell. The result may provide new clue to explain immunoregulatory mechanism of MSC.
出处
《白血病.淋巴瘤》
CAS
2009年第1期1-4,共4页
Journal of Leukemia & Lymphoma
基金
国家高技术发展规划项目863项目(2001AA217131)
关键词
间质干细胞
初始T细胞
免疫调节
Mesenchymal stem cell
Naive T cells
Immunomodulatory